Brinckerhoff Comments on Proposed Legislation Aimed at Curbing Drug Prices
January 1, 2020
Law360
Partner Courtenay Brinckerhoff was quoted in a Law360 article, “Patent Legislation To Watch In 2020,” about a slew of pending bills aimed at curbing drug prices.
Brinckerhoff said the bills that have been proposed to date appear to need work and may not have their intended effect. “I don’t necessarily think they would achieve the intended purpose and would have a lot of unintended consequences,” she said. “Once people who understand the nitty gritty details of the patent system look at them, some of those will fall apart.”
People
Related News
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 5, 2025
In the News
Michael Bennett and Zack Flagel Explore Pro Tennis Antitrust Battle
Foley & Lardner LLP attorneys Michael Bennett and Zack Flagel assess the antitrust litigation embroiling professional tennis in their LawInSport article, "Break(ing) Point? The Antitrust Battle that Could Transform Professional Tennis."
June 4, 2025
In the News
Foley Attorneys Explore IP Considerations for AI-Generated Logos
Foley & Lardner LLP attorneys Von Bryant, Norm Rich, and Alex Liederman authored the Bloomberg Law article, "AI-Generated Logos Require Careful Steps to Protect IP Rights."